Our finding that high SK1 expression in tumours that also contain low levels of S1P4 exhibit significantly shorter disease-free survival and disease-specific survival compared with patients with low SK1 and S1P4 tumour expression suggests that a functional interaction between SK1 and S1P4 might operate in ER− breast cancer. This evidence concerns the gene S1PR4 and breast carcinoma.